# A Study of CT0596 in Plasma Cell Leukemia

> **NCT06988059** · EARLY_PHASE1 · RECRUITING · sponsor: **Institute of Hematology & Blood Diseases Hospital, China** · enrollment: 27 (estimated)

## Conditions studied

- Plasma Cell Leukemia

## Interventions

- **DRUG:** CAR-T cells Infusion chimeric antigen receptor T cells

## Key facts

- **NCT ID:** NCT06988059
- **Lead sponsor:** Institute of Hematology & Blood Diseases Hospital, China
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-25
- **Primary completion:** 2027-01-03
- **Final completion:** 2027-12-31
- **Target enrollment:** 27 (ESTIMATED)
- **Last updated:** 2025-08-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06988059

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06988059, "A Study of CT0596 in Plasma Cell Leukemia". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06988059. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*